Losartan Potassium USP — Class II drug recall D-0341-2021
Terminated recall by PD-Rx Pharmaceuticals, Inc., reported 2021-05-05, distributed in AK, AZ, CA, CO, FL, KY, MA, MI…. CGMP deviation: Product found to contain trace amounts of NMBA
| Recall number | D-0341-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, United States |
| Recall initiated | 2019-03-08 |
| Classified | 2021-04-26 |
| Reported by FDA | 2021-05-05 |
| Terminated | 2021-06-16 |
| Distributed | AK, AZ, CA, CO, FL, KY, MA, MI, MN, NC, OH, OR, WI, WY |
| Quantity | 576 bottles |
| Reason classes | cgmp |
| NDC | 43063-0854, 43063-0854-60, 43063-0854-90 |
| Lot numbers | A19B99, B19A26, B19A69, E18F12, F18A12, F18F06, G18B43, G18C43, G18F75, H18D55, I18A11, I18E32, J18A90, J18D50, L18D01 |
| Expiration dates | 2019-09-30, 2019-11-30 |
Product
Losartan Potassium USP, 50 mg, RX Only, Pkg By PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 60 Tablets NDC: 43063-854-60; b) 90 Tablets NDC: 43063-0854-90
Reason for recall
CGMP deviation: Product found to contain trace amounts of NMBA
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0341-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.